Assenagon Asset Management
IRMD icon

Assenagon Asset Management’s iRadimed IRMD Stock Holding History

Assenagon Asset Management’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-66,795
Closed -$1.89M – 1463
2022
Q4 		$1.89M Hold
66,795
– – 0.01% 832
2022
Q3 		$2.01M Sell
66,795
-4,464
-6% -$155K 0.01% 716
2022
Q2 		$2.42M Hold
71,259
– – 0.01% 762
2022
Q1 		$3.19M Buy
71,259
+54,311
+320% +$2.51M 0.01% 669
2021
Q4 		$783K Sell
16,948
-14,380
-46% -$580K ﹤0.01% 1105
2021
Q3 		$1.05M Sell
31,328
-372
-1% -$12.7K ﹤0.01% 896
2021
Q2 		$932K Sell
31,700
-5,237
-14% -$144K ﹤0.01% 931
2021
Q1 		$952K Buy
36,937
+9,919
+37% +$237K ﹤0.01% 938
2020
Q4 		$616K Sell
27,018
-35,978
-57% -$831K ﹤0.01% 815
2020
Q3 		$1.35M Buy
62,996
+21,897
+53% +$492K 0.01% 690
2020
Q2 		$954K Buy
+41,099
New +$882K 0.01% 809

Other funds holding IRMD

NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMC
RK Capital Management (Colorado) Denver, Colorado $324K AUM 47.52% 1-Year Est. Return
BCM
Bares Capital Management Austin, Texas $1.08B AUM 38.13% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Assenagon Asset Management's IRMD Position: Q1 2023 in Review

Assenagon Asset Management sold out of iRadimed (IRMD) in Q1 2023, closing a stake of 66,795 shares — an estimated $1.89M sold.

Assenagon Asset Management first reported a position in IRMD in Q2 2020 and held it in 11 quarters. The position peaked at $3.19M in Q1 2022. 89 funds tracked by Wall St. Rank hold IRMD as of Q1 2023.

  • Assenagon Asset Management reported no remaining iRadimed position as of Q1 2023 after selling out during the quarter.
  • Assenagon Asset Management sold 66,795 iRadimed shares in Q1 2023, an estimated $1.89M.
  • Assenagon Asset Management first reported a position in iRadimed in Q2 2020 and held it in 11 quarters.
  • Assenagon Asset Management's iRadimed position peaked at $3.19M in Q1 2022.
  • 89 funds tracked by Wall St. Rank held iRadimed as of Q1 2023.

Based on Assenagon Asset Management's 13F filing for Q1 2023, filed 18 Apr 2023.